INTRODUCTION
Substantial progress has occurred in the field of pediatric surgery and in particular, in the approach to surgical diseases of the newborn. This progress is due to many factors including advances in instrumentation, an improved understanding of the pathophysiology of disease entities and a greater ability to support critically ill neonates. In addition, improved prenatal diagnostic techniques have allowed optimal planning for perinatal care. This article will review several pediatric surgical diseases in which significant progress has been recorded.
PRENATAL DIAGNOSIS AND INTERVENTIONS
Largely as a result of advances in prenatal imaging, congenital anomalies of the fetus have been identified with increasing sensitivity and at earlier gestational ages. In addition, standard prenatal ultrasonography has been supplemented by ultra-fast magnetic resonance imaging to help clarify anatomic details in those fetuses with identified congenital anomalies ( Fig. 1 ). Early and accurate detection allows appropriate parental counseling, optimization of perinatal management and in selected cases, prenatal operative intervention. This improved imaging and earlier detection has also provided clinicians with a clearer picture of the natural history of many congenital anomalies once thought uniformly fatal. It was surmised that to alter the natural course of these lethal conditions, in utero intervention was necessary to arrest the pathologic consequences (such as insurmountable pulmonary hypoplasia).
Pioneers in the field of fetal surgery had to overcome numerous medical and ethical hurdles in bringing these techniques to reality. One of the most formidable challenges has been the management of preterm labor related to uterine irritability. Advances in anesthetic management and tocolysis have allowed the field to advance (1). Fetal surgical intervention places at risk both the fetus and the mother. Comprehensive prenatal counseling regarding maternal risk and therapeutic alternatives is essential. There are selected congenital anomalies identified that, while not candidates for fetal intervention, benefit from perinatal care available at a tertiary care facility. Care can thus be optimized through prenatal assessment and formulation of a perinatal plan of care. For fetuses with prenatally diagnosed congenital anomalies, and clinical features (such as hydrops) indicative of impending demise, fetal surgery may be an alternative.
The first such condition to undergo open fetal therapy was congenital diaphragmatic hernia. Initial clinical interventions involved in utero repair of the diaphragmatic defect in the most severely effected fetuses. Unfortunately, open prenatal repair yielded results no better than conventional postnatal care (2). Subsequently, a trial of fetal tracheal occlusion to promote lung growth through elevation of intratracheal pressures and reduction of the herniated viscera yielded survivors in 5 of 15 cases for fetuses with the most severe anatomic defects (3). In addition to open fetal tracheal occlusion, there is currently an NIHsponsored trial of fetoscopic tracheal occlusion for the management of diaphragmatic hernia.
Fetal surgical intervention has been employed for a variety of additional congenital anomalies (Table 1) . Congenital cystic adenomatoid malformations (CCAM) of the lung can grow quite large resulting in limitation of both ipsilateral and contralateral lung development. In the most severe cases, fetal hydrops develops and the condition is uniformly fatal. It is in this group that open fetal resection has been employed successfully in 11 of 21 cases (4). Successful fetal intervention has also been reported for resection of giant sacrococcygeal teratomas (SCT). Left untreated, large SCTs result in high output cardiac failure, fetal hydrops and intrauterine demise. Prenatal resection has been used successfully in 3 of 4 treated fetuses (4). More recently, fetal therapy has been employed for the non-lethal congenital anoma-ly myelomeningocele (MMC). Myelomeningocele is associated with significant disabilities including notably, paraplegia and hydrocephalus. It was theorized, and demonstrated in an animal model, that fetal repair of the defect would result in an improved neurologic outcome (5). Initial clinical experience with fetal intervention for MMC has been promising (4). Repair of the defect has resulted in a attenuation of hindbrain herniation characteristic of MMC obviating the need for ventriculoperitoneal shunting. In addition, the observed motor functional level has been better than predicted for the anatomic level of the neurologic lesion (4). Currently, an NIH-sponsored trial is underway comparing open fetal repair to traditional postnatal therapy.
As an outgrowth of the fetal tracheal occlusion studies for congenital diaphragmatic hernia, ex-utero intrapartum therapy (EXIT) was conceived (6). The EXIT strategy involves delivery of the fetus by planned Caesarean section with preservation of uteroplacental blood flow to ensure adequate gas exchange for the fetus while intervention proceeds. This approach allows controlled evaluation of the fetal airway including endoscopy, intubation or tracheostomy. In a series of fetuses undergoing EXIT procedure, an overall mean of 30 minutes of uteroplacental support was achieved allowing interventions to occur in a controlled fashion (7). The EXIT strategy has been applied to a variety of fetal anomalies (Table 1) .
CONGENITAL DIAPHRAGMATIC HERNIA
Occurring with a frequency of approximately 1 of every 2500 live births, congenital diaphragmatic hernia continues to challenge clinicians. The hallmark of the disease is severe pulmonary hypoplasia with associated pulmonary hypertension. Despite dramatic advances in care of the newborn (as well as fetal surgical intervention), the survival for this anomaly is only 60-65 % at most centers (8). Standard therapies utilized for other causes of neonatal pulmonary failure, such as exogenous surfactant and nitric oxide, have been applied to the CDH population. While incremental and anecdotal improvements have been demonstrated, overall survival is little changed (9, 10). Extracorporeal membrane oxygenation has been used for the most severely effected group. This intervention has shown an increase in survival when used in the population with a predicted mortality of 80 % or more but also may be predictive of a group with higher long-term pulmonary morbidity (11, 12) . More recently, management strategies have focused on the "gentilation" or permissive hypercapnea approach. Gentilation is a ventilatory strategy that minimizes additional barotrauma by limiting airway inflating pressures while tolerating supraphysiologic arterial carbon dioxide levels and lower post-ductal oxygen saturations. Utilizing this approach, centers have reported improved survival rates (78-94 %) (13, 14) . Most recently, a single center multidisciplinary team model of CDH care was associated with a survival rate of 93 % in a cohort with a predicted sur- (59) Myelomeningocele (60) Conditions treated by EXIT Reversal of tracheal occlusion (7) Giant fetal neck masses (61) Resection of CCAM (7) Unilateral pulmonary agenesis (7) Congenital high airway obstruction (7) Bridge to separation of twins (7) Bridge to ECMO (7) Severe fetal hydrothorax (62) vival rate of 68 % (15) . These results emphasize the impact of consistency and experience in the care of this challenging clinical problem. Also on the horizon for treatment of this condition are the use of liquid ventilation strategies (16) and potent pulmonary vasodilators such as sildenafil (Viagra™) (17) . Preliminary animal trials, and subsequent human use of perfluorocarbon liquid ventilation media have been promising (16, (18) (19) (20) . Improved gas exchange and pulmonary compliance, effective pulmonary clearance and enhanced anatomic detail have been demonstrated with the use of liquid ventilation in the CDH population (Fig. 2) . Clinical trials are expected to resume (16) . Sildenafil has been shown to be a potent and selective pulmonary vasodilator in neonatal pulmonary failure models (17) . As the severe pulmonary hypertension is one of the most challenging obstacles in the care of the these neonates, such agents offer promise.
EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO)
An offshoot of adult cardiopulmonary bypass, extracorporeal membrane oxygenation provides gas exchange in the newborn with extreme respiratory insufficiency. Since the initiation of an ECMO registry in 1985, 18,088 neonatal respiratory ECMO runs have been recorded (21) . The number of neonatal ECMO runs peaked in 1992 with 1517 cases but more recently has run closer to 650 cases per year. The decrease in neonatal ECMO utilization is likely due to improvements in ventilatory techniques (permissive hypercapnea), and adjunctive measures (surfactant therapy, nitric oxide). The ECMO survival rate for all neonatal respiratory indications is 86 % including a survival to discharge of 78 % (21) . In the neonatal population, the most frequent indication for ECMO is meconium aspiration syndrome which has a survival rate exceeding 90 % (Table 2) . Unfortunately, ECMO for diaphragmatic hernia has only a 53 % survival rate, likely due to the selection bias for the most severely compromised neonates. Traditionally ECMO required cannulation of both the jugular vein and carotid artery (veno-arterial bypass). More recently, venovenous bypass has been increasingly employed. This technique requires cannulation of only the jugular vein with a custom double lumen cannula that provides both inflow and outflow. Venous access only was utilized in more than one-third of neonatal ECMO runs according to the most recent data (21) . This technique obviates the need for arterial cannulation with its potential morbidity. This technique is ideally suited for neonates in whom support of oxygenation only is at issue. Venovenous access can also be achieved by percutaneous methods in selected cases (22) .
GASTROSCHISIS
Gastroschisis occurs with a frequency of 1 in 3,000-5,000 live births. The perinatal period is marked by extreme fluid and heat loss if the exposed viscera are not appropriately protected. Traditionally, gastroschisis represented a surgical emergency necessitating care in the operating room to attempt bowel reduction and closure of the abdominal wall defect. This intervention was quite demanding on the newborn often resulting in difficulties with bowel and renal perfusion as well as respiratory problems related to the increase in intraabdominal pressure that occurs from reduction of viscera. More recently, a prefabricated silo with a spring loaded anchoring ring has been commercially available (23). This device is typically applied to the neonate in the NICU and acts to protect the bowel, prevent heat loss, and allow for gradual reduction of the abdominal contents at the bedside (Fig. 3) . Once complete reduction has been achieved, a formal closure of the abdominal wall can occur in the operating room with the hemodynamics of the newborn optimized. A delayed primary reduction and closure is associated with fewer complications, shorter time until feeds and in some series, a shorter length of hospital stay (24) . As suggested, gastroschisis represents a spectrum of disease and risk categorization is necessary to determine if primary closure or closure in a delayed fashion is best (25) . There also exists recent de- bate regarding the optimal timing and location of delivery of fetuses with gastroschisis. Pre-term delivery has been advocated to minimize the damage to the eviscerated bowel caused by exposure to amniotic fluid. It is thought that minimizing the length of time the bowel is exposed to amniotic fluid is associated with a better functional outcome. In addition, gradual constriction of the abdominal wall defect, or growth of the bowel without an increase in diameter of the defect may limit blood flow and further injure the bowel. There is still insufficient evidence that preterm delivery improves outcome and thus further investigation is warranted (26) .
HIRSCHSPRUNG'S DISEASE
Progress has been made in the treatment of Hirschsprung's disease on both medical and surgical levels. Insight regarding the molecular origin of the disease may prove beneficial in future treatment strategies. For instance, modulation of nitric oxide synthase that has been shown to be deficient in the effected bowel segment affected by Hirschsprung's disease may prove efficacious (27) . In addition, several genetic abnormalities (RET proto-oncogene, endothelin receptors) have been linked to Hirschsprung's disease and in the future, such genetic abnormalities may prove to be candidate targets for gene therapy (28) (29) (30) . The surgical management of Hirschsprung's disease has changed substantially in recent years. From the traditional three-stage management approach (colostomy, pull-through, colostomy takedown) has evolved the primary pull-through in the newborn eliminating the need for colostomy and takedown (31) . Primary pull-through in the newborn evolved as a result of improved instrumentation, namely laparoscopic stapling devices adapted for use in the creation of the pouch in the newborn. Initial experience has been quite promising (31) . A laparoscopic approach to the correction of Hirschsprung's disease has also been reported (32) . This procedure utilizes minimally invasive techniques to biopsy and mobilize the diseased colon with the resected bowel removed transanally. This approach has had excellent results to date and is appealing from a cosmetic standpoint. Most recently, surgeons have performed the bowel resection and anastomosis entirely transanally (33, 34) ( Fig. 4) . As the majority of newborns with Hirschsprung's have disease limited to the rectosigmoid colon, they are candidates for a transanal approach. As no abdominal incision is required, it is the most cosmetically appealing and has had very good initial results. Careful long-term follow-up will be essential to demonstrate the durability of all of these newer techniques.
NECROTIZING ENTEROCOLITIS (NEC)
The etiology of necrotizing enterocolitis remains poorly understood. The final pathophysiologic event is a hypoxic-ischemic insult at the level of the intestinal mucosa. Improvements in outcome of affected neonates are largely related to improvements in critical care. From a surgical perspective, the indications for operative intervention have narrowed over time.
Most surgeons reserve operative intervention for those neonates with NEC and evidence of intestinal perforation or refractory sepsis. Relative indications for intervention include a fixed abdominal mass, abdominal wall erythema and portal venous air. The optimal surgical intervention remains controversial.
In the smallest neonates with NEC (< 1000 g), outcomes have traditionally been quite poor. In this subset of patients, placement of a peritoneal drain at bedside improved survival from 22 % in the laparotomy group to 69 % and obviated the need for emergent exploration in these critically ill neonates (35) . Recent studies have suggested however, that laparotomy can be performed safely in these extremely low birth weight neonates with an outcome comparable to drainage only (36, 37) . Thus, the surgical management of complicated NEC must be individualized and considered in the context of the physiologic stability of the neonate and the associated co-morbidity. A more thorough understanding of the disease leading to primary prevention would be the optimal long-term solution.
CONGENITAL HYPERINSULINISM
In the newborn period, the most common cause of recurrent hypoglycemia is congenital hyperinsulinism (formerly referred to as nesidioblastosis). The hallmark of this disease is the overproduction of insulin resulting in severe hypoglycemia that can result in irreversible brain damage. Significant progress has been made over the last decade in both the medical and surgical management of this disease. From a molecular level, it has been demonstrated that specific abnormalities of the subunits of the ATP-dependent potassium channel, the sulfonylurea receptor type 1 and the inward-rectifying potassium channel, are responsible for the impaired insulin secretion (38) . Hyperinsulinism resulting from these genetic abnormalities is unlikely to respond to medical therapy and surgery is often necessary. It has been recognized that at a molecular/histopathologic level, hyperinsulinism exists in two forms, diffuse variant involving all of the beta cells and a focal adenomatous process. Until recently, near total pancreatectomy was the procedure of choice as the distinction between the focal and diffuse processes was neither appreciated nor discernable pre-operatively. Recent advances in pre-operative evaluation namely, the acute insulin response to stimulation (AIRS) testing, have allowed clinicians to discriminate between the diffuse and focal variants based on response to calcium and tolbutamide injection (39, 40) . Infants with diffuse disease demonstrate no response to tolbutamide and are hyperresponsive to calcium administration. Infants with a focal lesion will have a positive response to both tolbutamide and calcium administration. In addition, interventional radiologic techniques have also allowed localization of focal lesions based on portal vein sampling of insulin during selective arterial infusion of calcium into the gastroduodenal, splenic and superior mesenteric arteries (39) . This discrimination is quite important as it is now appreciated that a substantial proportion of these children have the focal variant (38, 41) . Pre-op-erative identification of infants with the focal variant may allow correction with a limited pancreatic resection. The disease remains quite challenging.
MINIMALLY INVASIVE SURGERY
With advances in instrumentation, as well as operator experience, minimally invasive techniques have been increasingly applied to newborn diseases. Laparoscopy has been used for many years to evaluate the contralateral inguinal region to identify a hernia in newborns and children with a unilateral hernia on clinical exam (42) . This approach minimizes the negative inguinal exploration rate in those newborns in whom contralateral evaluation is justified. A laparoscopic approach to the repair of pediatric hernias has also been described (43) . Initial results parallel the conventional open repair with minimal morbidity but certainly, long-term durability and morbidity must be evaluated (44) . Laparoscopy is now commonly used to treat infantile pyloric stenosis (45) . The minimally invasive approach is as safe, and typically associated with a shorter operative time (46) . The laparoscopic approach is particularly useful in cases in which the pyloric "olive" is quite large and would be difficult to deliver through a wound. Minimally invasive techniques have also been applied in highly selected hands to other conditions in the abdomen such as duodenal atresia, jejunal atresia, malrotation, imperforate anus, ovarian cyst and Hirschsprung's disease (32, (47) (48) (49) (50) (51) . Minimally invasive techniques have been employed in the chest to close patent ductus arteriosus, perform pulmonary resection, and repair tracheo-esophageal fistula (52) (53) (54) . As instrumentation is increasingly miniaturized, robotic surgical techniques are being applied in the newborn period (55) .
